Trial Profile
Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms ATRAS
- 02 Mar 2015 New trial record